Алунбриг
(бригатиніб)
(90)
(thirty)
(Таб)
Alunbrig (brigatinib) 90 мг 30 таб, Laos mfd.
In Stock
Indications for use
AlunbrigTM is indicated for monotherapy in adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor.
AlunbrigTM is indicated for monotherapy in adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have previously been treated with crizotinib.
-
Commercial name:Алунбриг
-
Сhemical name:бригатиніб
-
Dosage:90
-
Quantity:thirty
-
Release form:Таб
-
Производитель:Lucius
Дякую за швидку відповідь, оперативну та надійну доставку та довіру! Замовляли вперше але лануємо замовляти знову. Рекомендую!